爱朋医疗
(300753)
| 流通市值：9.56亿 | | | 总市值：14.87亿 |
| 流通股本：8099.49万 | | | 总股本：1.26亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 87,752,962 | 422,170,460.93 | 295,814,795.96 | 188,697,092.52 |
| 营业收入 | 87,752,962 | 422,170,460.93 | 295,814,795.96 | 188,697,092.52 |
| 二、营业总成本 | 86,636,436.82 | 415,602,661.18 | 292,904,087.92 | 189,199,229.09 |
| 营业成本 | 29,912,167.64 | 145,446,943.68 | 106,515,141.71 | 71,707,085.9 |
| 税金及附加 | 911,642.4 | 4,189,189.65 | 2,784,305 | 1,900,736.75 |
| 销售费用 | 24,765,360.77 | 147,710,315.48 | 99,351,711.9 | 58,813,450.91 |
| 管理费用 | 22,771,358.41 | 80,881,602.64 | 55,238,400.24 | 36,915,897.31 |
| 研发费用 | 7,677,023.64 | 36,549,133.77 | 28,317,853.54 | 19,565,950.61 |
| 财务费用 | 598,883.96 | 825,475.96 | 696,675.53 | 296,107.61 |
| 其中:利息费用 | 332,166.81 | 3,072,146.7 | 1,005,978.71 | 622,349.99 |
| 其中:利息收入 | 199,875.55 | 2,306,440.16 | 1,647,777.07 | 1,328,269.84 |
| 加:投资收益 | 85,115.95 | -1,438,422.34 | -776,086.29 | 189,618.81 |
| 资产处置收益 | - | 6,655.9 | 6,655.9 | 3,040.26 |
| 资产减值损失(新) | - | -470,734.61 | 32,000 | 32,000 |
| 信用减值损失(新) | 1,642,108.37 | -7,723,971.82 | -5,911,842.31 | -3,761,357.87 |
| 其他收益 | 1,263,464.93 | 17,025,165.06 | 12,897,715.71 | 10,351,442.77 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,107,214.43 | 13,966,491.94 | 9,159,151.05 | 6,312,607.4 |
| 加:营业外收入 | 838.32 | 180,826.61 | 48,570 | 8,376 |
| 减:营业外支出 | 2,002,597.43 | 338,537.13 | 317,687.3 | 257,548.4 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,105,455.32 | 13,808,781.42 | 8,890,033.75 | 6,063,435 |
| 减:所得税费用 | 978,147.17 | 5,358,727.18 | 1,494,704.03 | 2,973,312.51 |
| 六、净利润 | 1,127,308.15 | 8,450,054.24 | 7,395,329.72 | 3,090,122.49 |
| 持续经营净利润 | 1,127,308.15 | 8,450,054.24 | 7,395,329.72 | 3,090,122.49 |
| 归属于母公司股东的净利润 | 1,356,953.49 | 8,277,352.58 | 6,797,785.28 | 2,767,900.36 |
| 少数股东损益 | -229,645.34 | 172,701.66 | 597,544.44 | 322,222.13 |
| (一)基本每股收益 | 0.01 | 0.07 | 0.05 | 0.02 |
| (二)稀释每股收益 | 0.01 | 0.07 | 0.05 | 0.02 |
| 九、综合收益总额 | 1,127,308.15 | 8,450,054.24 | 7,395,329.72 | 3,090,122.49 |
| 归属于母公司股东的综合收益总额 | 1,356,953.49 | 8,277,352.58 | 6,797,785.28 | 2,767,900.36 |
| 归属于少数股东的综合收益总额 | -229,645.34 | 172,701.66 | 597,544.44 | 322,222.13 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-21 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |